Readystate Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$665K Buy
+10,600
New +$848K 0.03% 534
2025
Q2
Sell
-36,400
Closed -$3.67M 657
2025
Q1
$3.67M Sell
36,400
-40,500
-53% -$4.08M 0.12% 142
2024
Q4
$6.87M Sell
76,900
-132,600
-63% -$11.7M 0.21% 104
2024
Q3
$17.6M Buy
209,500
+139,300
+198% +$11M 0.33% 61
2024
Q2
$5.41M Buy
70,200
+12,600
+22% +$922K 0.18% 100
2024
Q1
$3.95M Buy
+57,600
New +$3.7M 0.06% 412
2023
Q2
Sell
-6,600
Closed -$330K 295
2023
Q1
$330K Buy
+6,600
New +$311K 0.03% 191

Other funds holding BSX

Readystate Asset Management's BSX Position: Q1 2026 in Review

Readystate Asset Management opened a new position in Boston Scientific (BSX) in Q1 2026: 3,540 shares worth $222K. The stake represents 0.01% of the portfolio and ranks #735 among its holdings. This is a return to the name: Readystate Asset Management previously reported a position in BSX as recently as Q1 2025.

Readystate Asset Management first reported a position in BSX in Q1 2025 and has held it in 2 quarters since. The position peaked at $285K in Q1 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Readystate Asset Management held 3,540 shares of Boston Scientific worth $222K as of Q1 2026.
  • Boston Scientific was a new Readystate Asset Management position in Q1 2026.
  • Boston Scientific made up 0.01% of Readystate Asset Management's portfolio in Q1 2026, its #735 holding.
  • Readystate Asset Management first reported a position in Boston Scientific in Q1 2025 and has held it in 2 quarters since.
  • Readystate Asset Management's Boston Scientific position peaked at $285K in Q1 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Readystate Asset Management's 13F filing for Q1 2026, filed 15 May 2026.